BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
RESEARCH & DEVELOPMENT: Industrial expertise in the handling of: Aluminium and hydrides, azide
reagent, boranes, boron trifluoride, butyllithium, carbon disulphide, chlorine,
dimethyl sulfate, epichlorohydrin, ethylene oxide, hydrazine sodium azide,
hydrogen peroxide, lithium diisopropylamide, methyl bromide, nitric acid,
oxalyl chloride, peracids, phosgene, phosphorus oxychloride, phosphorus
pentachloride, sodium amide, sodium cyanide, sulfonitric acid
In-house manufacture or in situ generation of: Azido alkyl acetate, bocchloride,
diazo ethyl acetate, diphenylphosphorylazide (DPPA), N-vinyl-Oalkyl
carbamate, ruppert reagent: CF3-Si (CH3) 3, trimethylsilylazide (TMS-
N3)
Reaction portfolio: Aldol condensation, Baeyer-Villiger oxidation, Claisen
condensation, Chloromethylation, Diazo coupling, Diels-Alder reaction,
Friedel-Crafts reaction, Hydroxyethylation, Knoevenagel condensation,
Mannich reaction, Methylation, Reimer-Tiemann reaction, Vilsmeier
formylation, Wittig reaction
PRODUCTS ON MARKET: Generic drugs: Synthetic and botanical
Synthetic intermediates: Tetrazoles, nitro compounds, phosgene derivatives
Services: API supply, custom manufacturing, project manufacturing
PRODUCTS IN DEVELOPMENT: Name Status
Under secrecy agreements
OmniGene Bioproducts Inc.
763-D Concord Avenue
Cambridge MA 02138, US
Phone: (617) 576-1966; Fax: (617) 547-9256
Web: www.omnigenebioproducts.com
E-mail: info@omnigenebioproducts.com
KEY PERSONNEL: Janice G. Pero, Ph.D.; Chairman and President
Dr. R. Rogers Yocum; Sr. Program Director
EMPLOYEES: 10+ employees
HISTORY: Founded in September 1995
Began biotech R&D in October 1995
Formerly a division of OmniGene Inc. and BioTechnica International Inc.;
acquired bioproducts division from OmniGene Inc.
FACILITIES: 1,500 sq. ft. headquarters
6,000 sq. ft. R&D facility
STOCK-FINANCIAL HISTORY: Privately held
BUSINESS STRATEGY: Contract research and licensing
Expand bioproducts R&D
AGREEMENTS: Name Products Content of Agreement Date
BASF AG specialty chemicals licensing agreement 1/99
F. Hoffmann-La
Roche AG
specialty chemicals licensing agreement 1/88
Genencor
International Inc.
industrial enzymes licensing agreement 1/99
RESEARCH & DEVELOPMENT: Genetic engineering of microorganisms to produce specialty products, such
as vitamins, amino acids, enzymes, other proteins and fine chemicals
Copyright ©2006 AHC Media ® 289